Ken Fisher Amphastar Pharmaceuticals, Inc. Transaction History

Fisher Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$45.51 - $65.0 $2,639 - $3,770	58 New	58 $2,000
Q3 2018 Oct 24, 2018	SELL	$15.39 - $19.38 $2.01 Million - $2.53 Million	-130,468 Closed	0 $0
Q2 2018 Jul 09, 2018	SELL	$14.63 - $19.6 $1.11 Million - $1.49 Million	-76,133 Reduced 36.85%	130,468 $1.99 Million
Q1 2018 May 11, 2018	SELL	$17.23 - $20.35 $1.7 Million - $2.01 Million	-98,678 Reduced 32.32%	206,601 $3.87 Million
Q1 2018 Apr 19, 2018	BUY	$17.23 - $20.35 $1.31 Million - $1.55 Million	76,002 Added 33.15%	305,279 $5.72 Million
Q4 2017 Jan 24, 2018	BUY	$17.76 - $19.75 $303,589 - $337,606	17,094 Added 8.06%	229,277 $4.41 Million
Q3 2017 Oct 17, 2017	BUY	$14.73 - $17.99 $3.13 Million - $3.82 Million	212,183	212,183 $3.79 Million

279

36.8M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.58B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.